Status:
ENROLLING_BY_INVITATION
Saskatoon Berry on Metabolism and Gut Microbiota in Healthy Subjects
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Health Sciences Centre Foundation, Manitoba
Conditions:
Nutritional and Metabolic Diseases
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Diabetes becomes epidemic in worldwide countries. Nine out of ten diabetic patients are type 2 diabetes (T2D). T2D is characterized by insulin resistance and obesity. Uncontrolled diabetes leads to se...
Detailed Description
Subject recruitment: Healthy subjects and prediabetes (males and females, 18-75 years of age) in Winnipeg, who are voluntarily signing an informed consent approved by Research Ethics Board in Universi...
Eligibility Criteria
Inclusion
- Healthy subjects living in Winnipeg.
- Willingness to sign an informed consent.
Exclusion
- 1\. History of myocardial infarction, stroke, hypertension, diabetes, hyperlipidemia, chronic kidney disease.
- 2\) Participants are taking hypoglycemic, anti-hypertensives, lipid lowering medications or antibiotics within a 1 month.
Key Trial Info
Start Date :
January 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04809688
Start Date
January 8 2023
End Date
December 20 2026
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Manitoba
Winnipeg, Manitoba, Canada, R3E 3P4